Health Catalyst Stock Performance
| HCAT Stock | USD 2.42 0.04 1.68% |
The company retains a Market Volatility (i.e., Beta) of 2.56, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Health Catalyst will likely underperform. At this point, Health Catalyst has a negative expected return of -0.21%. Please make sure to check out Health Catalyst's potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if Health Catalyst performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Health Catalyst has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Actual Historical Performance (%)
One Day Return 1.68 | Five Day Return 1.26 | Year To Date Return (67.03) | Ten Year Return (93.82) | All Time Return (93.82) |
1 | Will Health Catalyst Inc. stock hit Wall Street targets - Weekly Trend Recap Stock Portfolio Risk Control - newser.com | 10/21/2025 |
2 | Health Catalyst Q3 Earnings Snapshot | 11/10/2025 |
3 | Health Catalyst, Inc. Q3 2025 Earnings Call Transcript | 11/12/2025 |
4 | Stifel Nicolaus Cuts Health Catalyst Price Target to 3.75 | 11/14/2025 |
5 | Health Catalyst Buy, Sell, or Hold Post Q3 Earnings | 11/19/2025 |
6 | Disposition of 3360 shares by Ross David Coy of Health Catalyst at 3.3627 subject to Rule 16b-3 | 11/21/2025 |
7 | Disposition of 55715 shares by Daniel Burton of Health Catalyst at 2.9002 subject to Rule 16b-3 | 12/01/2025 |
8 | Disposition of 47997 shares by Larson-green Julie of Health Catalyst at 2.6741 subject to Rule 16b-3 | 12/03/2025 |
9 | Disposition of 27425 shares by Benjamin Landry of Health Catalyst at 2.6373 subject to Rule 16b-3 | 12/05/2025 |
10 | Benjamin Landry Sells 27,425 Shares of Health Catalyst Stock | 12/11/2025 |
11 | Can Health Catalyst Inc. stock rebound after recent weakness - 2025 AllTime Highs Verified Technical Trade Signals - DonanmHaber | 12/19/2025 |
12 | Decision Diagnostics vs. Health Catalyst Head-To-Head Review | 12/26/2025 |
| Begin Period Cash Flow | 106.3 M | |
| Total Cashflows From Investing Activities | -22.9 M |
Health Catalyst Relative Risk vs. Return Landscape
If you would invest 292.00 in Health Catalyst on September 28, 2025 and sell it today you would lose (50.00) from holding Health Catalyst or give up 17.12% of portfolio value over 90 days. Health Catalyst is currently does not generate positive expected returns and assumes 4.17% risk (volatility on return distribution) over the 90 days horizon. In different words, 37% of stocks are less volatile than Health, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Health Catalyst Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Health Catalyst's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Health Catalyst, and traders can use it to determine the average amount a Health Catalyst's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0504
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HCAT |
Based on monthly moving average Health Catalyst is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Health Catalyst by adding Health Catalyst to a well-diversified portfolio.
Health Catalyst Fundamentals Growth
Health Stock prices reflect investors' perceptions of the future prospects and financial health of Health Catalyst, and Health Catalyst fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Health Stock performance.
| Return On Equity | -0.31 | ||||
| Return On Asset | -0.0474 | ||||
| Profit Margin | (0.34) % | ||||
| Operating Margin | (0.10) % | ||||
| Current Valuation | 248.92 M | ||||
| Shares Outstanding | 70.73 M | ||||
| Price To Earning | (2.62) X | ||||
| Price To Book | 0.51 X | ||||
| Price To Sales | 0.54 X | ||||
| Revenue | 306.58 M | ||||
| Gross Profit | 150.11 M | ||||
| EBITDA | (10.65 M) | ||||
| Net Income | (69.5 M) | ||||
| Cash And Equivalents | 403.35 M | ||||
| Cash Per Share | 7.37 X | ||||
| Total Debt | 402.26 M | ||||
| Debt To Equity | 0.53 % | ||||
| Current Ratio | 5.15 X | ||||
| Book Value Per Share | 4.70 X | ||||
| Cash Flow From Operations | 14.56 M | ||||
| Earnings Per Share | (1.58) X | ||||
| Market Capitalization | 171.17 M | ||||
| Total Asset | 858.93 M | ||||
| Retained Earnings | (1.19 B) | ||||
| Working Capital | 139.8 M | ||||
| Current Asset | 216.75 M | ||||
| Current Liabilities | 48.69 M | ||||
About Health Catalyst Performance
Assessing Health Catalyst's fundamental ratios provides investors with valuable insights into Health Catalyst's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Health Catalyst is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.14) | (0.14) | |
| Return On Capital Employed | (0.13) | (0.14) | |
| Return On Assets | (0.08) | (0.08) | |
| Return On Equity | (0.19) | (0.20) |
Things to note about Health Catalyst performance evaluation
Checking the ongoing alerts about Health Catalyst for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Health Catalyst help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Health Catalyst generated a negative expected return over the last 90 days | |
| Health Catalyst has high historical volatility and very poor performance | |
| Health Catalyst has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 306.58 M. Net Loss for the year was (69.5 M) with profit before overhead, payroll, taxes, and interest of 150.11 M. | |
| Over 79.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Decision Diagnostics vs. Health Catalyst Head-To-Head Review |
- Analyzing Health Catalyst's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Health Catalyst's stock is overvalued or undervalued compared to its peers.
- Examining Health Catalyst's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Health Catalyst's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Health Catalyst's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Health Catalyst's stock. These opinions can provide insight into Health Catalyst's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Health Stock Analysis
When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.